Desok Kim

University of North Carolina at Chapel Hill

Papers

1

Total Citations

70

H-Index

1

About

Desok Kim is a biomedical researcher whose work bridges cancer biology and quantitative imaging. His key research areas include prostate cancer progression, androgen receptor signaling, and the development of image analysis tools for histopathology. Kim’s major contribution lies in elucidating the mechanisms of castration-resistant prostate cancer. His highly cited 2002 study on the CWR22 xenograft model—cited over 70 times—demonstrated that androgen receptor expression persists and drives cellular proliferation even after androgen deprivation, providing critical insight into the transition from hormone-dependent to recurrent growth. This work has helped shape understanding of treatment resistance in prostate cancer. Beyond this, Kim has advanced automated image cytometry and tissue microarray analysis, enabling high-throughput, quantitative assessment of biomarkers in cancer tissues. His interdisciplinary approach, combining molecular biology with computational pathology, has produced tools that enhance reproducibility in cancer research. With a career spanning over two decades, Kim’s contributions continue to inform both basic science and translational efforts aimed at overcoming therapeutic resistance.

Research Focus

Key Achievements

1
H-Index
1
Papers
70
Total Citations
70
Avg Citations/Paper
🏆 Most Cited Paper
Androgen Receptor Expression and Cellular Proliferation During Transition from Androgen-Dependent to Recurrent Growth after Castration in the CWR22 Prostate Cancer Xenograft
70 citations · 2002
📈 Most Prolific Year: 2002 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: University of North Carolina at Chapel Hill

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago